Source: Virtual Congress 2020 – Biological aspects of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
V. Bajoriunas (Kaunas, Lithuania), I. Bajoriuniene (Kaunas, Lithuania), E. Stankevicius (Kaunas, Lithuania). Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer. 3938

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Late Breaking Abstract: Expression of S100A4 in COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2) Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis Year: 2020 Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Antagonizing COVID19-induced GPR4 alleviates lung and kidney injury Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 Association of the Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 Genetic Polymorphisms with Non-small Cell Lung Cancer in Taiwan Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Investigating Transient Receptor Potential V4 channel induced bronchospasm Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Late Breaking Abstract - Role of phosphorylated Signal Transducer and Activator of Transcription 5 (pSTAT5) in non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI) Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Late Breaking Abstract - Organoids and lung-on-chip to study SARS-CoV-2-mediated lung injury Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019